Publication: The Case for Reforming Drug Naming: Should Brand Name Trademark Protections Expire upon Generic Entry?
Open/View Files
Date
2016
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
Public Library of Science
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Sarpatwari, Ameet, and Aaron S. Kesselheim. 2016. “The Case for Reforming Drug Naming: Should Brand Name Trademark Protections Expire upon Generic Entry?” PLoS Medicine 13 (2): e1001955. doi:10.1371/journal.pmed.1001955. http://dx.doi.org/10.1371/journal.pmed.1001955.
Research Data
Abstract
Ameet Sarpatwari and Aaron Kesselheim explore whether stripping branded drugs of trademark protection would improve the efficiency and fairness of health care.
Description
Other Available Sources
Keywords
Medicine and Health Sciences, Health Care, Health Care Policy, Drug Policy, Public and Occupational Health, Pharmacology, Drug Research and Development, Drug Marketing, Health Care Providers, Medical Doctors, Physicians, People and Places, Population Groupings, Professions, Drugs, Social Sciences, Sociology, Marketing, Drug Regulation, Allied Health Care Professionals
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service